Diagnosis of MGRS in Patients With Paraproteinemias: Clinical, Anatomopathological and Pathophysiological Study

Performance of a Fast-track Pathway for Giant Cell Arteritis Diagnosis

NCT06742671 ·Status: RECRUITING

Describe the Progression of Inflammatory Orbitopathy and the Biological Progression of Patients Receiving Second-line Treatment

NCT07117981 ·Status: RECRUITING

Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years

NCT00307671 ·Status: COMPLETED ·Phase: PHASE4

Autoreactive B Cells in Membranous Nephropathy

NCT04095156 ·Status: RECRUITING

A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

NCT06962800 ·Status: RECRUITING ·Phase: PHASE3

Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy

NCT02647255 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis

NCT02556866 ·Status: TERMINATED ·Phase: PHASE2

Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis

NCT05623592 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN)

NCT05162066 ·Status: TERMINATED ·Phase: PHASE2

Stratified Therapy on Pediatric AAGN

NCT05969522 ·Status: RECRUITING ·Phase: PHASE4

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis

NCT00987389 ·Status: COMPLETED ·Phase: PHASE3

Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.

NCT04662723 ·Status: RECRUITING ·Phase: PHASE4

MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.

NCT07000292 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

The Efficacy and Safety of Treatment with Telitacicept in Antineutrophil Cytoplasmic Antibody-associated Nephritis (AAGN)

NCT06656962 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Short-term Glucocorticoid Combined with MMF for IgG4-RD

NCT06663618 ·Status: RECRUITING ·Phase: NA

Complement C5 mAb in the Treatment of Anti-GBM Disease

NCT06513338 ·Status: COMPLETED ·Phase: PHASE2

Comparison of ANCA and Anti-GBM Auto-antibodies Removal Kinetics Between Plasma Exchanges and Immunoadsorption in Patients With ANCA-associated Vasculitis or Anti-GBM Disease

NCT03635385 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy

NCT02981212 ·Status: UNKNOWN ·Phase: PHASE4

Clinical Characteristics of Aquagenic Pruritus in Patients With Myeloproliferative Neoplasms

NCT03688490 ·Status: COMPLETED

From Immune System Damage to Podocyte Cell Damage: Prospective Database and Biological Collection of Patients (Children and Adults) With MGLS and HSFP

NCT04174066 ·Status: UNKNOWN

Nuclear Magnetic Resonance Spectroscopic Analysis of Urinary Metabolome in Sarcoidosis (RMN-SARCURINES)

NCT05181930 ·Status: COMPLETED

Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis)

NCT01862068 ·Status: COMPLETED

RItuximab From the FIRst Episode of Idiopathic Nephrotic Syndrome

NCT03970577 ·Status: UNKNOWN ·Phase: PHASE2

Juvenile Autoimmune Necrotizing Myopathies

NCT04295785 ·Status: UNKNOWN

Cardiovascular Involvement in Patients With Granulomatosis With Polyangiitis

NCT03782870 ·Status: UNKNOWN